about
From inflammation to sickness and depression: when the immune system subjugates the brainThe type 1 TNF receptor and its associated adapter protein, FAN, are required for TNFalpha-induced sickness behavior.Cytokine, sickness behavior, and depressionTwenty years of research on cytokine-induced sickness behaviorInflammation Models of Depression in Rodents: Relevance to Psychotropic Drug DiscoveryMechanisms of chemotherapy-induced behavioral toxicitiesAlcoholism and inflammation: neuroimmunology of behavioral and mood disordersSocial factors and individual vulnerability to chronic stress exposureTen years of Nature Reviews Neuroscience: insights from the highly citedInduction of IDO by bacille Calmette-Guérin is responsible for development of murine depressive-like behaviorInhibition of vagally mediated immune-to-brain signaling by vanadyl sulfate speeds recovery from sickness.A biological substrate for somatoform disorders: importance of pathophysiology.Dexamethasone up-regulates type II IL-1 receptor in mouse primary activated astrocytes.Activation of lung toll-like receptors does not exacerbate sickness responses to lipopolysaccharide in mice.CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depressionTemporal and spatial relationships between lipopolysaccharide-induced expression of Fos, interleukin-1beta and inducible nitric oxide synthase in rat brain.Cytokine-induced sickness behavior.Voluntary wheel running reverses age-induced changes in hippocampal gene expressionEffects of insulin-like growth factor-I on cytokine-induced sickness behavior in mice.In vitro and in vivo evidence for a role of the P2X7 receptor in the release of IL-1 beta in the murine brainInoculation of Bacillus Calmette-Guerin to mice induces an acute episode of sickness behavior followed by chronic depressive-like behavior.Cytokine, sickness behavior, and depression.Is there a role for glutamate-mediated excitotoxicity in inflammation-induced depression?Central administration of lipopolysaccharide induces depressive-like behavior in vivo and activates brain indoleamine 2,3 dioxygenase in murine organotypic hippocampal slice culturesTumor necrosis factor-alpha-induced sickness behavior is impaired by central administration of an inhibitor of c-jun N-terminal kinase.Cytokine-induced sickness behavior: where do we stand?Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms.How the immune and nervous systems interact during disease-associated anorexia.Lipopolysaccharide reduces incentive motivation while boosting preference for high reward in miceTumor necrosis factor(alpha) and insulin-like growth factor-I in the brain: is the whole greater than the sum of its parts?Fractalkine receptor (CX3CR1) deficiency sensitizes mice to the behavioral changes induced by lipopolysaccharideCentral administration of insulin-like growth factor-I decreases depressive-like behavior and brain cytokine expression in mice.Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice.Neuroprotective kynurenine metabolite indices are abnormally reduced and positively associated with hippocampal and amygdalar volume in bipolar disorder.Microglial/macrophage GRK2 determines duration of peripheral IL-1beta-induced hyperalgesia: contribution of spinal cord CX3CR1, p38 and IL-1 signaling.Intracerebroventricular administration of HIV-1 Tat induces brain cytokine and indoleamine 2,3-dioxygenase expression: a possible mechanism for AIDS comorbid depression.Peripheral indoleamine 2,3-dioxygenase 1 is required for comorbid depression-like behavior but does not contribute to neuropathic pain in mice.Reduction of kynurenic acid to quinolinic acid ratio in both the depressed and remitted phases of major depressive disorder.Acute hypoglycemia causes depressive-like behaviors in mice.Putative neuroprotective and neurotoxic kynurenine pathway metabolites are associated with hippocampal and amygdalar volumes in subjects with major depressive disorder
P50
Q24633527-E5526F02-0330-4A04-9A8C-98FCC67B1B76Q24648146-0B9E5DC3-32AE-410E-AF93-90094E51CB80Q24657818-7982749B-CCAF-441A-8EF3-65FE3EBE6E4DQ24684760-D7B77C57-688B-4E37-A318-E1AC98AAE7DFQ26749497-AEA5E019-8E2E-4023-A35E-78FA2FF93780Q26998870-E91DBA7A-8D67-418D-8E40-8BD74B154FA6Q28302013-9AEFCECB-8238-4253-8E12-5A9100F6A04AQ28302508-58E57B9D-1383-4E5D-890C-1240706220DFQ28386297-694603E4-A244-4713-B8C9-01AB15220B9AQ28508390-EE0C0A43-E4FF-4735-9E0F-24010791ABA8Q30476283-029346BA-109B-4559-91B7-8662F115D92BQ31137825-4D5AC268-D013-43B8-87B4-6E6A5AEC06F5Q31832314-ADF24AE8-1C7D-4FA9-BB9B-D220FAEEFA59Q33553907-31A90FBE-B7FB-4E7D-9BC2-DD1BA497C125Q33751166-D816437C-A0BA-4E9E-8B06-D2BD3E8C7867Q33844654-BF74133A-9C45-4FEF-BFE6-47AEB4BCB076Q33964676-0D7B651F-DE44-489D-900A-9FA772231DD4Q33998949-F0BE623D-6A9C-4CCA-A125-EA82EBA1DD10Q34007543-6695892A-8020-4C95-95B2-F9DEB8436772Q34011838-A316B7ED-F878-4EEA-9D37-E041B9A87966Q34012783-1EF9C193-73BE-488F-B546-DEACB48A98AEQ34018621-98E4F7B1-1C3C-456C-82DD-53BEBABF81AEQ34051382-1285F14C-5314-467D-8122-AB9F0A14F000Q34064890-19E5E733-3F64-42C7-80F1-B8A6AAD511D9Q34076200-4E208A2E-3452-4797-BA69-136AEA23FFDFQ34190014-2B7D9658-62B1-4666-92AA-9D10A73F587FQ34199974-DFF79485-E1D2-45A6-94C8-026D7AF75B03Q34305744-241766CD-E9B4-4BE8-B112-FA730FE3DFB6Q34357034-2B27B1A3-2DA9-42B2-9952-15DABEBA5707Q34390682-4911C34D-DE61-4F37-8A98-C4EAAF3B2189Q34478106-D7C766C8-F497-4DD9-A47D-DC5361769D88Q34611012-C54095A1-E5AC-4DDB-8DE3-86BBBD1A2AB5Q34655648-FA751E02-3CE3-4B1D-B0CB-FA2C6BA6749CQ34979782-F318DEA1-D247-462D-B52E-31159B1D689BQ34997832-95CBF317-1C5E-4FFF-996B-45F9FCF720E2Q35317241-6306E2D9-53D8-4BC1-BD10-AA525C48D30AQ35554122-60ADE419-F505-4C94-8B18-5FDBAC0F9492Q35554351-314B814C-2813-4A7E-8DAB-9E99DAFF8E87Q35631825-6115F15D-2FD4-452D-BE0F-E3B3BD09FE75Q35647362-349EA273-6681-41C7-A43F-F6CBEE26E9C0
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Robert Dantzer
@ast
Robert Dantzer
@en
Robert Dantzer
@es
Robert Dantzer
@nl
Robert Dantzer
@sl
type
label
Robert Dantzer
@ast
Robert Dantzer
@en
Robert Dantzer
@es
Robert Dantzer
@nl
Robert Dantzer
@sl
prefLabel
Robert Dantzer
@ast
Robert Dantzer
@en
Robert Dantzer
@es
Robert Dantzer
@nl
Robert Dantzer
@sl
P106
P1153
7102694522
P21
P213
0000 0001 1567 9579
P31
P496
0000-0001-9399-6107
P569
2000-01-01T00:00:00Z